How to Navigate the Huntington's Disease (HD) Big Data Maze?

被引：0
|
作者：
Thangaramanujam, Muthukumaran [1 ,2 ]
Hoblyn, Jennifer [1 ,2 ]
机构：
[1] Bloomfield Hosp, Dublin, Ireland
[2] Trinity Coll Dublin, Dublin, Ireland
来源：
NEUROTHERAPEUTICS | 2019年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
88
引用
收藏
页码：1383 / 1383
页数：1
相关论文
共 50 条
  • [41] Epidemiology of Huntington's Disease (HD) in the US Medicare Population
    Exuzides, Alex
    Crowell, Valerie
    Reddy, Sheila Reiss
    Chang, Eunice
    Yohrling, George
    NEUROLOGY, 2020, 94 (15)
  • [42] Comorbidities in Huntington's disease: An Enroll-HD analysis
    Mills, J.
    Long, J.
    Vaidya, J.
    Sampaio, C.
    Sathe, S.
    MOVEMENT DISORDERS, 2022, 37 : S303 - S304
  • [43] Silent stiffness: an unusual presentation of Huntington's Disease (HD)
    Fossa Riglos, M.
    Santos, J. M.
    Arakaki, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E220 - E220
  • [44] DYSPHAGIA IN HUNTINGTON'S DISEASE (HD): A LONGITUDINAL, OBSERVATIONAL STUDY
    Schradt, Falk
    Geitner, Carolin
    Lindner-Pfleghar, Beate
    Rea, Daniela
    Hamilton, Alison
    Lang, Christina
    Suessmuth, Sigurd D.
    Weydt, Patrick
    Schumann, Beate
    Werner, Cornelius
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A57 - A57
  • [45] Functional analysis of the Huntington's disease (HD) gene promoter
    Coles, R
    Caswell, R
    Rubinsztein, DC
    HUMAN MOLECULAR GENETICS, 1998, 7 (05) : 791 - 800
  • [46] Impact of Caffeine Intake on Huntington's Disease (HD) Course
    Duru, Cecile
    Simonin, Clemence
    Richard, Florence
    Hincker, Pascale
    Salleron, Julia
    Charles, Perrine
    Youssov, Katia
    Burnouf, Sylvie
    Azulay, Jean-Philippe
    Verny, Christophe
    Tranchant, Christine
    Goizet, Cyril
    Defebvre, Luc
    Sablonniere, Bernard
    Romon, Monique
    Buee, Luc
    Amouyel, Philippe
    Godefroy, Olivier
    Duerr, Alexandra
    Bachoud-levi, Anne-Catherine
    Blum, David
    Krystkowiak, Pierre
    NEUROLOGY, 2010, 74 (09) : A414 - A414
  • [47] Biomarkers for the experimental therapeutics of Huntington's disease (HD) and Parkinson's disease (PD)
    Shoulson, I
    BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 47 - 49
  • [48] Refining the Language of Huntington's Disease Progression with the Huntington's Disease Integrated Staging System (HD-ISS)
    Sampaioa, Cristina
    Kostyk, Sandra K.
    Tabrizie, Sarah J.
    Rosser, Anne E.
    JOURNAL OF HUNTINGTONS DISEASE, 2024, 13 (02) : 115 - 118
  • [49] Frontal neuropsychiatric syndromes in Huntington's disease (HD) and Parkinson's disease (PD).
    Hulvershorn, LA
    Stout, JC
    Paulsen, JS
    Siemers, E
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 133 - 133
  • [50] Can Behavioral Changes on the UCSD Huntington's Disease Behavioral Questionnaire (HD-BQ) Distinguish Patients Transitioning to Manifest Huntington's Disease (HD)?
    Haque, Ayesha
    Nam, Seon K.
    Park, Sungmee
    Nathan, Ajay S.
    Haque, Ameera
    Gilbert, Paul E.
    Corey-Bloom, Jody
    ANNALS OF NEUROLOGY, 2017, 82 : S179 - S180
12345